PD-1 and PD-L1 inhibitors are not a wholly new concept. In fact, the first checkpoint inhibitor in the market, Yervoy (ipilimumab) from Bristol Myers Squibb, targeted a different immune checkpoint ...

Objective Patients with increased PD-L1 + host cells in tumours are more potent to benefit from antiprogrammed death-1/programmed death ligand-1 (PD-L1) treatment, but the underlying mechanism is ...

If you have non-small cell lung cancer (NSCLC), your doctor will recommend PD-L1 testing. This test will help your doctor understand if you can be treated with a type of cancer drug called immune ...

Introduction: To design effective small molecule inhibitors targeting the immune checkpoint PD-1/PD-L1 and to explore their inhibitory activity. Methods: In this paper, a total of 69 PD-1/PD-L1 ...

Online conversations among HCPs exhibited mixed reactions to this news, echoing the cautious optimism that accompanied discussions about lecanemab earlier in the year. Some HCPs were especially ...

Genomic landscape study of esophago-gastric adenocarcinoma (EGAC) in young patients under the age of 30 years. Relationship between the number of biopsy specimens and PD-L1 positivity.

The Union Budget 2025-26 has drawn mixed reactions from the industry associations in Tiruchi region. Terming the Budget “growth-oriented and inclusive,” P. Gopalakrishnan, Regional Chairman ...

The Union Budget presented by Finance Minister Nirmala Sitharaman on Saturday has received mixed reactions with the opposition describing it as ‘disappointing and pro-rich’, while ruling party ...

Lawmakers on Monday began discussing two government bills aimed at boosting the stock of residential units and providing affordable housing, but not all were convinced this was enough to drive ...